Department of Parasitology, Laboratory of Applied Toxinology on Anti-parasitic Drugs, Instituto Adolfo Lutz, São Paulo, SP, Brazil.
Planta Med. 2011 Apr;77(6):572-85. doi: 10.1055/s-0030-1250663. Epub 2011 Jan 17.
Leishmaniasis is a neglected infectious disease caused by kinetoplastid protozoans. An urgent need for novel chemotherapeutics exists. The current approaches to discover new antileishmanial compounds present many drawbacks, including high-cost and time-consuming bioassays. Thus, advances in leishmaniasis treatment are limited, and the development of screening assays is hindered. The combination of multidisciplinary approaches using standardised methods and synchronous projects could be an alternative to develop novel drugs for leishmaniasis treatment. In this review, we discuss the current status of leishmaniasis occurrence and treatment. In addition, we address the advantages and limitations of in vitro leishmaniasis bioassays and discuss the findings of drug discovery research using natural products. Finally, we comprehensively review the marine natural products that are active against Leishmania spp., including their natural sources and bioactivity profile.
利什曼病是一种由动基体原生动物引起的被忽视的传染病。迫切需要新的化学疗法。目前发现新的抗利什曼原虫化合物的方法存在许多缺点,包括高成本和耗时的生物测定。因此,利什曼病治疗的进展受到限制,筛选试验的发展受到阻碍。使用标准化方法和同步项目的多学科方法的结合可能是开发治疗利什曼病的新型药物的一种替代方法。在这篇综述中,我们讨论了利什曼病发生和治疗的现状。此外,我们还讨论了体外利什曼病生物测定的优缺点,并讨论了使用天然产物进行药物发现研究的结果。最后,我们全面综述了对抗利什曼原虫属有效的海洋天然产物,包括它们的天然来源和生物活性特征。